Secukinumab Is Associated With Improvements in Real-World Effectiveness Outcomes Through 12 Months of Follow-Up in Patients With Plaque Psoriasis: Analysis of US Dermatology Electronic Medical Records. J of Skin [Internet]. 2019 Mar. 11 [cited 2025 Apr. 19];3(2):173. Available from: https://skin.dermsquared.com/skin/article/view/530